Newsletter | July 30, 2024

07.30.24 -- Cell Therapies For Solid Tumors: Optimizing Your Approach To Achieve Regulatory Approval

FEATURED EDITORIAL

Cell Therapies For Solid Tumors: Optimizing Your Approach To Achieve Regulatory Approval

Developing and ultimately obtaining approval of cell therapies for solid tumors requires an organized and scientifically rigorous approach. This article is a helpful road map of considerations.

INDUSTRY INSIGHTS

Simultaneous Spray Drying For Combination Dry Powder Inhaler Formulations

Three combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Tips For Viral Vector Production

Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.

Harness High-Quality PBPK Modeling To Enhance Clinical Readiness

Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.

Nanoparticle Enabled Formulation And Drug Delivery Solutions

Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Approaching IND: What To Consider In Early Development

When preparing for IND submission, developers must consider multiple components. Explore tips for optimizing your early development program and the benefits of housing all activities under one roof.

MOST POPULAR NEWS

Innovent & WeComput Announce Strategic Partnership To Advance AI Drug Discovery

IASO Bio Receives U.S. FDA Approval Of IND Application For Equecabtagene Autoleucel

Apollo Therapeutics & Oxford Univ Enter Into Drug Discovery & Dev Collaboration

TIXiMED Receives IND Approval From The FDA For Its Novel Oral Antidiabetic, TIX100

Zymeworks Announces FDA Clearance Of IND Application For ZW191

Irish Scientists Pinpoint New Drug Target For RSV

Funding Boosts Endometriosis Drug Discovery Efforts

Charles River Laboratories & Autobahn Labs Announce Collaborative Program

NeOnc Initiates Cohort 3 In Phase 1 Clinical Trial Of NEO212

Defence Granted Cnri-H From The CNL To Accelerate The Dev Of Its Radio-Immuno-Conjugates Program

SciSparc: MitoCareX Confirms Potential Significant Role Of Its Drug Target In Non-Small Cell Lung Cancer

SOLUTIONS

Mechanistic Chromatography Modeling To Accelerate Process Development

Small Molecule APl and HPAPI Development Capacity Update